zamtocabtagene autoleucel (MB-CART2019.1) Clinical Trials

2 actively recruiting trials across 1 location

Filter by location:

Other1 trial

Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms

Phase 2

Gilbert, Arizona1 trial

DALY II USA/ MB-CART2019.1 for DLBCL

Banner MD Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.